• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    West Pharmaceutical Services, Inc. Common Stock (NY:WST)

    412.62 -4.05 (-0.97%)
    Official Closing Price Updated: 7:00 PM EDT, Oct 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about West Pharmaceutical Services, Inc. Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    18 19 Next >
    News headline image
    What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call ↗
    West Pharmaceutical Services (NYSE:WST) reported third-quarter results that exceeded its expectations, driven by continued demand for high-value product components, including those used in GLP-1... 
    Via MarketBeat
    Topics Earnings
    News headline image
    WST Q3 deep dive: Biologics and regulatory tailwinds fuel margin expansion, HVP mix shift continues
    Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q3 2026, with sales up 8.7% year on year to $87... 
    Via StockStory
    S&P 500 Unusual Volume Movers for October 29, 2026 ↗
    Via Chartmill
    Topics Stocks
    S&P 500 Top Movers: Today's US Session Gainers and Losers ↗
    Via Chartmill
    Topics Stocks
    West Pharmaceutical Services (NYSE:WST) Q3 Beat and Raised Guidance Signal Strong Momentum ↗
    Via Chartmill
    News headline image
    West (WST) Q3 2026 Earnings Call Transcript ↗
    GLP-1 demand drives HVP components to 53% of revenue with 20% organic growth. 
    Via The Motley Fool
    Topics Earnings
    S&P 500 Gap Movers: October 29, 2026 Session ↗
    Via Chartmill
    Topics Stocks
    News headline image
    West Pharmaceutical Services (NYSE:WST) beats expectations in strong Q3 2026, full-year outlook slightly exceeds expectations
    Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 8.7... 
    Via StockStory
    News headline image
    West Pharmaceutical Services earnings: what to look for from WST
    Healthcare products company West Pharmaceutical Services (NYSE:WST) will be announcing earnings results this Thursday morning. Here’s what to expect. West Ph... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    3 Low-Volatility Stocks We’re Skeptical Of
    Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Lu... 
    Via StockStory
    Topics Economy
    News headline image
    1 Cash-Producing Stock on Our Buy List and 2 Facing Challenges
    A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc... 
    Via StockStory
    Topics Economy Firearms
    News headline image
    Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST)
    Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
    Via StockStory
    Topics Economy
    News headline image
    1 S&P 500 Stock with Exciting Potential and 2 We Ignore
    While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec... 
    Via StockStory
    Topics Economy Stocks
    News headline image
    1 Surging Stock with Solid Fundamentals and 2 That Underwhelm
    The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab... 
    Via StockStory
    Topics Economy
    News headline image
    3 Profitable Stocks with Warning Signs
    Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
    Via StockStory
    Topics Economy Supply Chain
    News headline image
    1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Ignore
    Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
    Via StockStory
    Topics Economy
    News headline image
    1 Mid-Cap Stock on Our Buy List and 2 Facing Headwinds
    Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
    Via StockStory
    Topics Economy
    News headline image
    1 Healthcare Stock with Exciting Potential and 2 We Avoid
    Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be... 
    Via StockStory
    Topics Economy
    News headline image
    3 Cash-Heavy Stocks We Approach with Caution
    Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg... 
    Via StockStory
    Topics Economy
    News headline image
    3 Reasons to Avoid WST and 1 Stock to Buy Instead
    West Pharmaceutical Services has been on fire lately. In the past six months alone, the company’s stock price has rocketed 43%, reaching $339.52 per share. T... 
    Via StockStory
    News headline image
    The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings Call
    West Pharmaceutical Services posted a solid Q2, with revenue and adjusted earnings per share exceeding Wall Street expectations, while the market response re... 
    Via StockStory
    Topics Earnings
    Uncover the latest developments among S&P500 stocks in today's session. ↗
    Via Chartmill
    News headline image
    Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
    What Happened? A number of stocks fell in the morning session after concerns grew over a rising number of uninsured patients. The trend was highlighted in HC... 
    Via StockStory
    News headline image
    WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook
    Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 13.... 
    Via StockStory
    News headline image
    West Pharmaceutical Services Q2 Earnings Call Highlights ↗
    West Pharmaceutical Services (NYSE:WST) raised its full-year 2026 outlook after reporting second-quarter results that topped management’s expectations, supported by strong demand for high-value product... 
    Via MarketBeat
    Topics Earnings
    News headline image
    Full Transcript: West Pharmaceutical Servs Q2 2026 Earnings Call ↗
    West Pharmaceutical Servs (NYSE:WST) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide... 
    Via Benzinga
    Topics Earnings
    These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗
    Via Chartmill
    News headline image
    West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars
    Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 13.8%... 
    Via StockStory
    Topics Economy
    News headline image
    West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For
    Healthcare products company West Pharmaceutical Services (NYSE:WST) will be announcing earnings results tomorrow before market open. Here’s what to expect. W... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    3 Reasons WST is Risky and 1 Stock to Buy Instead
    Over the past six months, West Pharmaceutical Services has been a great trade, beating the S&P 500 by 21.8%. Its stock price has climbed to $353.68, represen... 
    Via StockStory
    Topics Stocks
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    18 19 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.